Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) saw unusually-high trading volume on Friday . Approximately 1,246,208 shares were traded during trading, an increase of 261% from the previous session's volume of 344,943 shares.The stock last traded at $15.72 and had previously closed at $15.67.
Analyst Ratings Changes
Separately, Royal Bank Of Canada reaffirmed an "outperform" rating on shares of Reckitt Benckiser Group in a report on Thursday. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Reckitt Benckiser Group presently has a consensus rating of "Buy".
View Our Latest Analysis on RBGLY
Reckitt Benckiser Group Stock Up 0.3%
The stock's fifty day moving average price is $15.34 and its 200-day moving average price is $14.23. The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01.
Reckitt Benckiser Group Cuts Dividend
The company also recently declared a dividend, which was paid on Thursday, September 25th. Stockholders of record on Monday, August 11th were given a dividend of $0.2106 per share. The ex-dividend date of this dividend was Friday, August 8th. This represents a dividend yield of 341.0%.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
